Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Anti-inflammatory activity and molecular mechanism of Oolong tea theasinensin.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Source:
Publisher: Royal Society of Chemistry Country of Publication: England NLM ID: 101549033 Publication Model: Print Cited Medium: Internet ISSN: 2042-650X (Electronic) Linking ISSN: 20426496 NLM ISO Abbreviation: Food Funct Subsets: MEDLINE
- Publication Information:
Original Publication: Cambridge : Royal Society of Chemistry
- Subject Terms:
- Abstract:
Oolong tea theasinensins are a group of tea polyphenols different from green tea catechins and black tea theaflavins, and they are considered as bioactive compounds in Oolong tea. In the present study, based on the properties of theasinensin and information about inflammatory processes, we investigated the anti-inflammatory activity and molecular mechanisms of theasinensin A (TSA) in both cell and animal models. In the cell model, TSA reduced the levels of pro-inflammatory mediators including inducible nitric oxide synthase (iNOS), nitric oxide (NO), interleukin-12 (IL-12) (p70), tumor necrosis factor alpha (TNF-α), and monocyte chemotactic protein-1 (MCP-1) induced by lipopolysaccharide (LPS). Cellular signaling analysis revealed that TSA downregulated MAPK/ERK kinase (MEK)-extracellular signal-regulated kinase (ERK) signaling. Pull-down assay and affinity data revealed that TSA might directly bind to MEK-ERK for the inhibitory action. In the animal model, TSA suppressed the production of IL-12 (p70), TNF-α, and MCP-1 and attenuated mouse paw edema induced by LPS.
- Accession Number:
0 (Anti-Inflammatory Agents)
0 (Benzopyrans)
0 (Ccl2 protein, mouse)
0 (Chemokine CCL2)
0 (Lipopolysaccharides)
0 (Phenols)
0 (Plant Preparations)
0 (Tea)
0 (Tumor Necrosis Factor-alpha)
0 (theasinensin A)
187348-17-0 (Interleukin-12)
31C4KY9ESH (Nitric Oxide)
EC 1.14.13.39 (Nitric Oxide Synthase Type II)
EC 1.14.13.39 (Nos2 protein, mouse)
EC 2.7.12.2 (MAP Kinase Kinase 1)
EC 2.7.12.2 (Map2k1 protein, mouse)
- Publication Date:
Date Created: 20140621 Date Completed: 20150330 Latest Revision: 20161125
- Publication Date:
20221213
- Accession Number:
10.1039/c4fo00152d
- Accession Number:
24947273
No Comments.